Citra Anticoagulants Announces CD Mark Approval for noClot400„ Anticoagulant Citrate Dextrose Solution Solution A ACDA U.S.P.

Citra Anticoagulants, Inc. announces that noClot-400's8482; Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., 4 milliliters known as ACD-A, has CE mark approval for use in the extracorporeal blood processing with Autologous Platelet Rich Plasma (PRP) Systems in the production of platelet rich plasma. noClot brand anticoagulants are the anticoagulants of choice to prevent clotting of the whole blood during extracorporeal blood processing with Autologous PRP Systems.

This regulatory achievement clears the way for Citra Anticoagulants to market this product throughout the European Union. It also allows our customers to include this product in kits that they market and distribute throughout the Eurpoean Union. noClot-400 joins its sister product noClot-50's8482; and is marketed and distributed exclusively by Citra Anticoagulants, Inc.

noClot-400 is a United States Pharmacopeia formulated product containing 4 milliliters of ACD-A. noClot brand anticoagulants prevent the coagulation of blood by virtue of their citrate ion'ss ability to chelate the ionized calcium present in blood to form a non-ionized calcium-citrate complex. When the total dose of citrate ions is greater than the total amount of ionized calcium, blood clotting is prevented.

About Citra Anticoagulants

Headquartered in Braintree, Massachusetts, Citra Anticoagulants, Inc. markets and distributes a multitude of citrate-based anticoagulants to the worldwide medical arena. For more about Citra and our products, visit our website at www.CitraAnticoagulants.com.

Contact:
Citra Anticoagulants, Inc.
Ronald H. Lewis, Ph.D., President
Adrienne Summers, Team Customer
asummers[att3cc.com
Tel: 781-848-2174
800-299-3411(USA only)
Fax: 781-848-6781




Citra Anticoagulants Announces CD Mark Approval for noClot400„ Anticoagulant Citrate Dextrose Solution Solution A ACDA U.S.P.



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***